financetom
Business
financetom
/
Business
/
Crypto Bill Would Put Investors at 'Immeasurable Risk,' SEC Chair Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crypto Bill Would Put Investors at 'Immeasurable Risk,' SEC Chair Says
May 22, 2024 10:24 AM

01:12 PM EDT, 05/22/2024 (MT Newswires) -- Securities and Exchange Commission Chair Gary Gensler on Wednesday warned of significant risks posed by a piece of legislation that seeks to establish a regulatory framework for digital assets.

"The Financial Innovation and Technology for the 21st Century Act would create new regulatory gaps and undermine decades of precedent regarding the oversight of investment contracts, putting investors and capital markets at immeasurable risk," Gensler said in a statement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
U.S. Gold Unit Gets Final Permit Approval for CK Project Development in Wyoming; Shares Rise
U.S. Gold Unit Gets Final Permit Approval for CK Project Development in Wyoming; Shares Rise
Nov 18, 2024
12:00 PM EST, 11/18/2024 (MT Newswires) -- U.S. Gold ( USAU ) shares were higher Monday after the company said its Gold King unit received a final permit approval from the air quality division of the Wyoming Department of Environmental Quality, clearing the way for development of the CK gold project. We are well advanced in our engineering studies and...
Novo Nordisk launches obesity drug Wegovy in China
Novo Nordisk launches obesity drug Wegovy in China
Nov 18, 2024
LONDON, Nov 18 (Reuters) - Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market. A spokesperson for the Danish drugmaker confirmed the news to Reuters after it was first reported by China-based financial media outlet Yicai. The price for a month's supply of the starter dose of Wegovy will...
BRIEF-MCB Withdraws Proposal To Acquire Whitestone Due To Whitestone Board's Entrenchment And Refusal To Engage
BRIEF-MCB Withdraws Proposal To Acquire Whitestone Due To Whitestone Board's Entrenchment And Refusal To Engage
Nov 18, 2024
Nov 18 (Reuters) - Whitestone REIT ( WSR ): * MCB WITHDRAWS PROPOSAL TO ACQUIRE WHITESTONE DUE TO WHITESTONE BOARD'S ENTRENCHMENT AND REFUSAL TO ENGAGE * MCB REAL ESTATE: CALLS ON INDEPENDENT TRUSTEES OF WHITESTONE TO INITIATE STRATEGIC REVIEW Source text: Further company coverage: ...
Update: Twist Bioscience Fiscal Q4 Loss Narrows, Revenue Rises
Update: Twist Bioscience Fiscal Q4 Loss Narrows, Revenue Rises
Nov 18, 2024
10:59 AM EST, 11/18/2024 (MT Newswires) -- (Updates with the latest stock movement in the last paragraph.) Twist Bioscience ( TWST ) reported a fiscal Q4 loss Monday of $0.59 per diluted share, narrower than its loss of $0.81 a year earlier. Analysts polled by Capital IQ expected a loss of $0.70. Revenue for the quarter ended Sept. 30 was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved